MedTrace Logo

Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

NCT01499927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74766

Last updated 2013-12-19

No results posted yet for this study

Summary

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Conditions

  • Infection as Complication of Medical Care

Interventions

OTHER

electronic reminders

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Juerg Blaser, Professor · University Hospital Zurich, Center for Clinical Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01499927 on ClinicalTrials.gov